Centor Score (Modified) Calculator

Centor Score (Modified) Calculator for Pediatrics. Approximate GAS probabilities by score are: score 0 about 1 to 2.5 percent, score 1 about 5 to 10 percent, score 2 about 11 to 17 percent, score 3 about 28 to 35 percent, and score 4 or higher about 51 to 53 percent. A score of 0 or 1 supports no testing and no antibiotics, since strep is very unlikely. Scores of 2 to 3 are the classic test-and-treat zone: perform rapid antigen detection (backed by culture in children if negative) and prescribe only if positive. A score of 4 or 5 carries the highest pretest probability, but note that even here roughly half of patients are culture-negative, so guideline-concordant care still favors confirmatory testing over blanket empiric antibiotics, which drove a 44 percent unnecessary-prescription rate in adults treated empirically at scores of 3 to 4.

How this calculator works

The modified Centor (McIsaac) score estimates the probability that an acute sore throat is caused by group A beta-hemolytic streptococcus, guiding decisions about testing versus empiric antibiotics. It awards one point each for tonsillar exudate or swelling, tender or swollen anterior cervical lymph nodes, absence of cough, and history of fever above 38 C. McIsaac added an explicit age adjustment: +1 point for ages 3 to 14, 0 points for ages 15 to 44, and -1 point for age 45 and older, reflecting the falling strep prevalence with age. The summed score ranges from -1 to 5.

When to use this calculator

Use it in the primary care or emergency evaluation of a patient aged 3 or older presenting with acute sore throat, to decide who warrants rapid antigen detection testing or throat culture and who can be reassured without a swab. It applies to otherwise immunocompetent outpatients. Do not use it in children under 3 (streptococcal pharyngitis and rheumatic fever are rare and presentation is atypical), in patients with recurrent tonsillitis being worked up for tonsillectomy, in those with stridor, drooling, or trismus suggesting peritonsillar abscess or epiglottitis, or to diagnose the many non-GAS causes of pharyngitis such as infectious mononucleosis, viral syndromes, or Fusobacterium (Lemierre).

Inputs used

  • Fever
  • Tonsillar exudate or swelling
  • Tender anterior cervical nodes
  • Absence of cough
  • Age

Clinical interpretation

Approximate GAS probabilities by score are: score 0 about 1 to 2.5 percent, score 1 about 5 to 10 percent, score 2 about 11 to 17 percent, score 3 about 28 to 35 percent, and score 4 or higher about 51 to 53 percent. A score of 0 or 1 supports no testing and no antibiotics, since strep is very unlikely. Scores of 2 to 3 are the classic test-and-treat zone: perform rapid antigen detection (backed by culture in children if negative) and prescribe only if positive. A score of 4 or 5 carries the highest pretest probability, but note that even here roughly half of patients are culture-negative, so guideline-concordant care still favors confirmatory testing over blanket empiric antibiotics, which drove a 44 percent unnecessary-prescription rate in adults treated empirically at scores of 3 to 4.

Worked example

A 30-year-old with tonsillar exudate (+1), tender anterior cervical nodes (+1), no cough (+1), reported fever (+1), age 15 to 44 (0) scores 3. In McIsaac's cohorts this corresponds to roughly a 28 to 35 percent likelihood of GAS. Under IDSA-aligned practice this patient should have a rapid antigen test or culture rather than automatic antibiotics: a positive test confirms treatment, while empiric antibiotics at a score of 3 alone would treat about two patients unnecessarily for each true strep case.

Limitations and safety notes

The score identifies streptococcal risk, not overall serious illness: it does not detect mononucleosis, gonococcal or Fusobacterium pharyngitis, or deep-space infection, and a low score does not exclude these. Its specificity is modest, so empiric treatment of high scores substantially overtreats, and it is not validated for repeated use in the same illness episode. Performance is weaker in adults than children and it has not been established in patients under 3 years, the immunocompromised, or populations with high acute rheumatic fever incidence where more liberal testing is warranted.

Frequently asked questions

How is the modified Centor score different from the original Centor score?

The original 1981 Centor rule used four criteria (exudate, tender anterior nodes, absent cough, history of fever) in adults only. McIsaac added an age adjustment (+1 for 3 to 14 years, -1 for 45 and older) so the tool could be applied across children and adults, since strep prevalence falls sharply with age.

Does a score of 4 or 5 justify antibiotics without testing?

Not by itself. Even at the highest scores only about half of patients are truly GAS-positive, so IDSA guidance still recommends confirmatory rapid antigen testing or culture before treatment. Empiric treatment at scores of 3 to 4 was shown to produce roughly 44 percent unnecessary antibiotic prescriptions in adults.

Can I use it in a 2-year-old?

No. The age adjustment starts at 3 years, and streptococcal pharyngitis, its suppurative complications, and rheumatic fever are uncommon below age 3, where presentation is also atypical. Testing decisions in that group should not rest on this rule.

A negative rapid strep test in a child with a high score — do I still need a culture?

Yes, in children and adolescents. Because untreated GAS in this group carries rheumatic fever risk and rapid tests are imperfectly sensitive, guidelines advise backup throat culture after a negative rapid test. In adults a negative rapid test generally does not require culture confirmation.

References

  • Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981. PMID: 6763125.
  • McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998. PMID: 9475915.
  • McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004. PMID: 15069046.
  • Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012. PMID: 22965026.

Editorial review and citation methodology

Reviewed by the Quick Medical Calculator Editorial Team. Last reviewed: June 23, 2026. The review checks calculator inputs, intended population, interpretation, limitations, and source alignment.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators